For instance, prolonged NF-κB activation and the subsequent production of pro-inflammatory chemokines in myeloid differentiation protein 88 (MyD88)-expressing epithelial ovarian cancer cells are involved in chemoresistance to paclitaxel, a crucial drug for standard first-line chemotherapy [24, 25]. Here, NFKB1 is linked to ovarian carcinoma.